Gastroenterology
News, opinions and meeting coverage in gastroenterology.
C. Difficile Inpatient Stays Long, Costly
LAS VEGAS -- Among the many factors that contribute to the burgeoning costs associated with Clostridium difficile infections are long hospital stays, particularly in intensive care units, and the need for multiple specialist consultations, a chart review determined.
Dec 08, 2012
Robin Gibb Looks at 'Spider Medicine' for Liver Cancer, Sources Say
Robin Gibb, a member of the BeeGees singing group, was hospitalized recently for complications related to liver cancer, a diagnosis that was made several months ago, according to several publications, and is reportedly investigating alternative treatments.
Nov 25, 2011
Consumer Group Urges Boxed Warning for PPIs
Citing research showing that withdrawal of proton pump inhibitors (PPIs) leads to severe rebound acid secretion -- potentially leaving patients permanently dependent on the drugs -- the consumer group Public Citizen has told the FDA that it should require black-box warnings with the drugs.
Aug 23, 2011
No Approval for Rifaximin in IBS
The FDA has indicated that, before the antibiotic drug rifaximin (Xifaxan) can be approved for treating irritable bowel syndrome, its manufacturer must provide data on how the agent should be used in retreating patients with recurrent symptoms, the company said.
Mar 08, 2011
FDA Warns GERD Drugs May Deplete Magnesium
WASHINGTON -- Use of prescription or over-the-counter proton pump inhibitors (PPI) for a year or longer may lead to low levels of circulating magnesium, which may increase the risk of leg spasms, arrhythmias, and seizures, according to an FDA warning.
Mar 02, 2011
FDA Panel Rejects Cystic Fibrosis Drug
SILVER SPRING, Md. -- An FDA advisory committee has voted against approval of liprotamase (Sollpura), a pancreatic enzyme product for cystic fibrosis and other diseases that cause pancreatic insufficiency, saying there is not enough evidence that the drug works better than agents already on the market.
Jan 12, 2011
AHA: FDA Drops Clopidogrel Bomb at AHA
ORLANDO -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, so the combination should be avoided.
Nov 17, 2009